![Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition: Trends in Pharmacological Sciences Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition: Trends in Pharmacological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/614450/4945048/gr1.jpg)
Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition: Trends in Pharmacological Sciences
![History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C | Medicina Universitaria History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C | Medicina Universitaria](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S166557961500037X:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfyDJ8Ru8hCz4cufi6EOoVuH+g9/Rhd6YTAHulOy6LMQxILNFTYCZhSR8uGzCT2WGbkRZ7HM5bV812J6FryBKq3kVAMFDAbI1SSLBuxy+wNgmzrLm+z5U2lrxZKMwiTwXHDiglAzAfQqKBoGNFODa51oiJWV2k0+Q22C/GJScHG3R3TfEJJ+kCq2Z5MtilkGkiUz+/brqigDEmPYmc2RmHN9BbC9KhxMOXstTE+l0X1ZK/q01S1wtmAl3eXA529nKz20mR2IbkWIRUyqENafYZp)
History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C | Medicina Universitaria
![Antiviral drug discovery: broad-spectrum drugs from nature - Natural Product Reports (RSC Publishing) DOI:10.1039/C4NP00085D Antiviral drug discovery: broad-spectrum drugs from nature - Natural Product Reports (RSC Publishing) DOI:10.1039/C4NP00085D](https://pubs.rsc.org/image/article/2015/NP/c4np00085d/c4np00085d-f2_hi-res.gif)
Antiviral drug discovery: broad-spectrum drugs from nature - Natural Product Reports (RSC Publishing) DOI:10.1039/C4NP00085D
![Emerging Trends, Challenges and Prospects in Antiviral Therapeutics and Drug Development for Infectious Diseases | Insight Medical Publishing Emerging Trends, Challenges and Prospects in Antiviral Therapeutics and Drug Development for Infectious Diseases | Insight Medical Publishing](https://ejbio.imedpub.com/articles-images/ejbio-Antiviral-drugs-6-2-26-g002.png)
Emerging Trends, Challenges and Prospects in Antiviral Therapeutics and Drug Development for Infectious Diseases | Insight Medical Publishing
![Molecules | Free Full-Text | Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses | HTML Molecules | Free Full-Text | Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses | HTML](https://www.mdpi.com/molecules/molecules-25-01800/article_deploy/html/images/molecules-25-01800-g001.png)
Molecules | Free Full-Text | Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses | HTML
![Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery | Future Virology Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery | Future Virology](https://www.futuremedicine.com/cms/10.2217/17460794.4.2.101/asset/images/medium/graphic2.gif)
Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery | Future Virology
![Frontiers | Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides | Microbiology Frontiers | Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides | Microbiology](https://www.frontiersin.org/files/Articles/65348/fmicb-04-00321-HTML/image_m/fmicb-04-00321-g003.jpg)
Frontiers | Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides | Microbiology
![Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/497-1/reproductive-cycle-hiv-1-sites-action-major-classes-antiretroviral-medications.jpg)